Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dakin

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Translational Research : the Journal of Laboratory and Clinical Medicine|June 16, 2009
Early evaluation of acute traumatic coagulopathy by thrombelastographyRoger C Carroll, Robert M Craft, Russell J Langdon, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
3-amido-4-anilinocinnolines as a novel class of CSF-1R inhibitorDavid A Scott, Les A Dakin, David J Del Valle, et al.
Organic Letters|July 29, 2014
A practical synthesis of indoles via a Pd-catalyzed C-N ring formationRishi G Vaswani, Brian K Albrecht, James E Audia, et al.
Bioorganic & Medicinal Chemistry Letters|August 13, 2008
Pyridyl and thiazolyl bisamide CSF-1R inhibitors for the treatment of cancerDavid A Scott, Brian M Aquila, Geraldine A Bebernitz, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2008
3-amido-4-anilinoquinolines as CSF-1R kinase inhibitors 2: Optimization of the PK profileDavid A Scott, Kirsten J Bell, Cheryl T Campbell, et al.
Diabetes Care|December 7, 2019
Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)Shelby D Reed, Yanhong Li, Helen A Dakin, et al.
Protein Science : a Publication of the Protein Society|September 24, 2017
The catalytic mechanism of cyclic GMP-AMP synthase (cGAS) and implications for innate immunity and inhibitionJustin Hall, Erik C Ralph, Suman Shanker, et al.
Health Technology Assessment (Winchester, England)|October 8, 2015
A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN)Usha Chakravarthy, Simon P Harding, Chris A Rogers, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2013
Mitigation of cardiovascular toxicity in a series of CSF-1R inhibitors, and the identification of AZD7507David A Scott, Les A Dakin, Kevin Daly, et al.
Journal of Medicinal Chemistry|December 23, 2016
Design, Synthesis, and Biological Activity of Substrate Competitive SMYD2 InhibitorsScott D Cowen, Daniel Russell, Leslie A Dakin, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Translational Research : the Journal of Laboratory and Clinical Medicine|June 16, 2009
Early evaluation of acute traumatic coagulopathy by thrombelastographyRoger C Carroll, Robert M Craft, Russell J Langdon, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
3-amido-4-anilinocinnolines as a novel class of CSF-1R inhibitorDavid A Scott, Les A Dakin, David J Del Valle, et al.
Organic Letters|July 29, 2014
A practical synthesis of indoles via a Pd-catalyzed C-N ring formationRishi G Vaswani, Brian K Albrecht, James E Audia, et al.
Bioorganic & Medicinal Chemistry Letters|August 13, 2008
Pyridyl and thiazolyl bisamide CSF-1R inhibitors for the treatment of cancerDavid A Scott, Brian M Aquila, Geraldine A Bebernitz, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2008
3-amido-4-anilinoquinolines as CSF-1R kinase inhibitors 2: Optimization of the PK profileDavid A Scott, Kirsten J Bell, Cheryl T Campbell, et al.
Diabetes Care|December 7, 2019
Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)Shelby D Reed, Yanhong Li, Helen A Dakin, et al.
Protein Science : a Publication of the Protein Society|September 24, 2017
The catalytic mechanism of cyclic GMP-AMP synthase (cGAS) and implications for innate immunity and inhibitionJustin Hall, Erik C Ralph, Suman Shanker, et al.
Health Technology Assessment (Winchester, England)|October 8, 2015
A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN)Usha Chakravarthy, Simon P Harding, Chris A Rogers, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2013
Mitigation of cardiovascular toxicity in a series of CSF-1R inhibitors, and the identification of AZD7507David A Scott, Les A Dakin, Kevin Daly, et al.
Journal of Medicinal Chemistry|December 23, 2016
Design, Synthesis, and Biological Activity of Substrate Competitive SMYD2 InhibitorsScott D Cowen, Daniel Russell, Leslie A Dakin, et al.
Pageof 8